Trials / Completed
CompletedNCT07468045
Functional Outcomes After Hyaluronic Acid Injections Following Arthroscopy
Evaluation of Functional Outcomes in Patients Receiving Hyaluronic Acid Injections Following Arthroscopic Procedure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Daewoong Group Indonesia · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to investigate the effect of hyaluronic acid injection on functional recovery and pain control in patients following knee or shoulder arthroscopy.
Detailed description
The study consists of three main periods: screening, treatment, and follow-up. During the screening period, subjects will provide written informed consent and undergo screening assessments. Only those who meet all inclusion criteria and none of the exclusion criteria will be enrolled in the study. During the treatment period, before completing the arthroscopy procedure, 10 mL of Hyaluronic Acid 0.5% (CG Synovia) will be injected into the joint cavity through the existing arthroscopy portal using a suitable needle attached to a Luer lock. The joint will then be moved through its full range of motion to ensure proper distribution of the product within the joint. During the follow-up period, subjects will attend visits up to 24 weeks after treatment, specifically at 4 weeks (Visit 3), 12 weeks (Visit 4), and 24 weeks (Visit 5) for evaluation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CG Synovia (Hyaluronic Acid 0.5%) | After arthroscopic procedure, attach a suitable needle to the Luer Lock and inject 10ml of CG Synovia into the joint cavity through a portal already placed in the joint for arthroscopy. Move the joint through full range of motion to allow CG Synovia to distribute throughout the joint, synovium, and joint surfaces. |
Timeline
- Start date
- 2024-10-09
- Primary completion
- 2025-07-07
- Completion
- 2025-07-07
- First posted
- 2026-03-12
- Last updated
- 2026-03-12
Locations
2 sites across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT07468045. Inclusion in this directory is not an endorsement.